Form 8-K - Current report:
SEC Accession No. 0001558370-21-011916
Filing Date
2021-08-18
Accepted
2021-08-18 16:36:06
Documents
14
Period of Report
2021-08-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gdnsf-20210812x8k.htm   iXBRL 8-K 40933
2 EX-99.1 gdnsf-20210812xex99d1.htm EX-99.1 11894
3 GRAPHIC gdnsf-20210812xex99d1001.jpg GRAPHIC 17715
  Complete submission text file 0001558370-21-011916.txt   192739

Data Files

Seq Description Document Type Size
4 EX-101.SCH gdnsf-20210812.xsd EX-101.SCH 3163
5 EX-101.LAB gdnsf-20210812_lab.xml EX-101.LAB 14104
6 EX-101.PRE gdnsf-20210812_pre.xml EX-101.PRE 9216
7 EXTRACTED XBRL INSTANCE DOCUMENT gdnsf-20210812x8k_htm.xml XML 4320
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Goodness Growth Holdings, Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56225 | Film No.: 211187070
SIC: 2834 Pharmaceutical Preparations